Related Experiment Video
Updated: Dec 21, 2025

07:00
A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects
Published on: August 14, 2013
13.4K
Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial
David M Wright1, Evgenia Konstantakopoulou2, Giovanni Montesano3
1Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom; Health Data Research UK, London, United Kingdom.
Ophthalmology
|May 14, 2020
Summary
Ocular hypertensive and glaucoma patients initially treated with medical therapy showed faster visual field progression than those treated first with selective laser trabeculoplasty (SLT). SLT may offer better long-term visual field preservation.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Visual Field Analysis
Background:
- Ocular hypertension and glaucoma management strategies vary.
- Early treatment decisions impact long-term visual field outcomes.
- Selective laser trabeculoplasty (SLT) is an alternative to medical therapy.
Purpose of the Study:
- To compare visual field progression between ocular hypertensive and glaucoma patients initially treated with medical therapy versus SLT.
- To evaluate the efficacy of initial treatment choice on visual field preservation.
Main Methods:
- Secondary analysis of the multicenter Laser in Glaucoma and Ocular Hypertension study.
- Standard automated perimetry used to measure visual fields (VFs) over 48 months.
- Hierarchical linear models and log-binomial regression analyzed VF progression rates.
Main Results:
- A higher proportion of eyes receiving initial medical therapy showed moderate or fast total deviation (TD) progression compared to SLT (26.2% vs. 16.9%).
- Similar trends observed for pointwise TD progression rates.
- Pointwise pattern deviation (PD) progression was also higher in the medical therapy group, though overall PD progression did not differ significantly.
Conclusions:
- Initial medical therapy led to a slightly greater proportion of patients experiencing rapid visual field progression compared to initial SLT.
- SLT may be associated with better visual field outcome preservation in the initial management of ocular hypertension and glaucoma.
Related Concept Videos
Open Angle Glaucoma: Treatment
886
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
886
Angle Closure Glaucoma: Treatment
1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K

